Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily

References

• Dy GW, Gore JL, Forouzanfar MH, et al. Global burden of urologic cancers, 1990–2013. Eur Urol. 2017;71(3):437–446.
   PubMed Web of Science ®Google Scholar
• Efesoy O, Apa D, Tek M, et al. The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. Aging Male. 2016;19:79–84.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship JE, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Yassin DJ, Doros G, Hammerer PG, et al. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014;11:1567–1576.]
   PubMed Web of Science ®Google Scholar
• Alvarez-Cubero MJ, Pascual-Geler M, Rivas A, et al. Lifestyle and dietary factors in relation to prostate cancer risk. Int J Food Sci Nutr. 2015;66:805–810.
   PubMed Web of Science ®Google Scholar
• Comhaire F, Mahmoud A. Preventing diseases of the prostate in the elderly using hormones and nutriceuticals. Aging Male. 2004;7:155–169.
   PubMedGoogle Scholar
• Ohwaki K, Endo F, Shimbo M, et al. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer. Aging Male. Forthcoming. [cited 2017 Mar 23]:[4 p.]. doi: 10.1080/13685538.2017.1301417.
   Web of Science ®Google Scholar
• Faydaci G, Bilal E, Necmettin P, et al. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels. Aging Male. 2008;11:189–192.
   PubMed Web of Science ®Google Scholar
• Kaufman JM. The effect of androgen supplementation therapy on the prostate. Aging Male. 2003;6:166–174.
   PubMedGoogle Scholar
• Singam P, Hong GE, Ho C, et al. Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice. Aging Male. 2015;18:112–117.
   PubMed Web of Science ®Google Scholar
• Fabiani R, Minelli L, Bertarelli G, et al. A Western dietary pattern increases prostate cancer risk: a systematic review and meta-analysis. Nutrients. 2016;8(10):E626.
   PubMed Web of Science ®Google Scholar
• Godos J, Bella F, Sciacca S, et al. Vegetarianism and breast, colorectal and prostate cancer risk: an overview and meta-analysis of cohort studies. J Hum Nutr Diet. 2017;30(3):349–359.
   PubMed Web of Science ®Google Scholar
• Grosso G, Bella F, Godos J, et al. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nut Rev. 2017; forthcoming.
   PubMed Web of Science ®Google Scholar
• Grosso G, Buscemi S, Galvano F, et al. Mediterranean diet and cancer: epidemiological evidence and mechanism of selected aspects. BMC Surg. 2013;13:S14.
   PubMed Web of Science ®Google Scholar
• Wang Y, Stevens VL, Shah R, et al. Dietary flavonoid and proanthocyanidin intakes and prostate cancer risk in a prospective cohort of US men. A J Epidemiol. 2014;179:974–986.
   PubMed Web of Science ®Google Scholar
• Grosso G, Bei R, Mistretta A, et al. Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark Ed). 2013;18:1017–1029.
   PubMed Web of Science ®Google Scholar
• Grosso G, Micek A, Godos J, et al. Dietary flavonoid and lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epi. 2017; forthcoming.
   PubMed Web of Science ®Google Scholar
• Grosman H, Fabre B, Lopez M, et al. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease. Aging Male. 2016;19:40–45.
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin DJ, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male. 2015;18:186–194.
   PubMed Web of Science ®Google Scholar
• Grosman H, Fabre B, Mesch V, et al. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer. Aging Male. 2010;13:87–92.
   PubMed Web of Science ®Google Scholar
• Vanella L, Russo GI, Cimino S, et al. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia. Urology. 2014;83:1444.e7–1444.e13.
   PubMed Web of Science ®Google Scholar
• McCann SE, Ambrosone CB, Moysich KB, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer. 2005;53:33–41.
   PubMed Web of Science ®Google Scholar
• Platz EA, Giovannucci E. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol. 2004;92:237–253.
   PubMed Web of Science ®Google Scholar
• Grosso G, Godos J, Lamuela-Raventos R, et al. A comprehensive meta-analysis on dietary flavonoid and lignan intake and cancer risk: level of evidence and limitations. Mol Nutr Food Res. 2017;61(4). doi: 10.1002/mnfr.201600930.
   PubMed Web of Science ®Google Scholar
• Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab. 1998;12:729–742.
   PubMed Web of Science ®Google Scholar
• Adlercreutz H, Mazur W. Phyto-oestrogens and western diseases. Ann Med. 1997;29:95–120.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Feng H, Qluwakemi B, et al. Phytoestrogens and risk of prostate cancer: an updated meta-analysis of epidemiologic studies. Int J Food Sci Nutr. 2017;68(1):28–42.
   PubMed Web of Science ®Google Scholar
• Grosso G, Marventano S, D'Urso M, et al. The Mediterranean healthy eating, ageing, and lifestyle (MEAL) study: rationale and study design. Int J Food Sci Nutr. 2017;68(5):577–586.
   PubMed Web of Science ®Google Scholar
• Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395.
   Google Scholar
• Marventano S, Mistretta A, Platania A, et al. Reliability and relative validity of a food frequency questionnaire for Italian adults living in Sicily, Southern Italy. Int J Food Sci Nutr. 2016;67(7):857–864.
   PubMed Web of Science ®Google Scholar
• Buscemi S, Rosafio G, Vasto S, et al. Validation of a food frequency questionnaire for use in Italian adults living in Sicily. Int J Food Sci Nutr. 2015;66:426–438.
   PubMed Web of Science ®Google Scholar
• Godos J, Marventano S, Mistretta A, et al. Dietary sources of polyphenols in the Mediterranean healthy Eating, Aging and Lifestyle (MEAL) study cohort. Int J Food Sci Nutr. 2017;68(6):750–756.
   PubMed Web of Science ®Google Scholar
• Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc. 2008;67:253–256.
   PubMed Web of Science ®Google Scholar
• Morgia G, Russo GI, Voce S, et al. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial). Prostate. 2014;74:1471–1480.
   PubMed Web of Science ®Google Scholar
• Russo GI, Castelli T, Urzi D, et al. Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematic review. Int J Urol. 2015;22:982–990.
   PubMed Web of Science ®Google Scholar
• van Die MD, Bone KM, Williams SG, et al. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int. 2014;113:E119–E130.
   PubMed Web of Science ®Google Scholar
• He J, Wang S, Zhou M, et al. Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies. World J Surg Oncol. 2015;13:231.
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Yang W, Bosland MC. Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol. 2014;140:116–132.
   PubMed Web of Science ®Google Scholar
• Magee PJ, Rowland IR. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr. 2004;91:513–531.
   PubMed Web of Science ®Google Scholar
• Ganry O. Phytoestrogens and prostate cancer risk. Prev Med. 2005;41:1–6.
   PubMed Web of Science ®Google Scholar
• Horvath LG, Henshall SM, Lee CS, et al. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res. 2001;61:5331–5335.
   PubMed Web of Science ®Google Scholar
• Ward HA, Kuhnle GG, Mulligan AA, et al. Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr. 2010;91:440–448.
   PubMed Web of Science ®Google Scholar
• Wang Q, Du Z, Zhang H, et al. Modulation of gut microbiota by polyphenols from adlay (Coix lacryma-jobi L. var. ma-yuen Stapf.) in rats fed a high-cholesterol diet. Int J Food Sci Nutr. 2015;66:783–789.
   PubMed Web of Science ®Google Scholar
• Akaza H, Miyanaga N, Takashima N, et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004;34:86–89.
   Google Scholar